SINOCELLTECH GROUP LIMITED revenue for the last year amounted to 1.89 B CNY, the most of which — 1.78 B CNY — came from its highest performing source at the moment, Recombinant Protein Drug, the year earlier bringing 1.00 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SINOCELLTECH GROUP LIMITED 1.89 B CNY, and the year before that — 1.02 B CNY.